When power morcellators are used in laparoscopic gynecological surgeries, it can spread uterine cancer through the abdomen. If you were not warned about this risk, you are not alone!
In April 2014, the FDA released a safety alert announcing that the use of power morcellators in some laparoscopic gynecological surgeries can spread previously undiagnosed cancer cells throughout the abdomen and pelvis of women, significantly increasing mortality rates.
If you or someone you care about has been diagnosed with a type of cancer called uterine sarcoma after undergoing a laparoscopic gynecological surgery, it is within your rights to take action against the device manufacturers for not providing appropriate warnings about the risk of using the device.
Power Morcellator’s Association with Uterine Cancer
According to the National Institutes of Health, most American women will develop uterine fibroids, or non-cancerous tumors that grow within a woman’s uterus, at some point in their lives. Many times, these fibroids will go unnoticed and will not require treatment. But for some women, fibroids will cause significantly uncomfortable symptoms and require treatment or surgery. Depending on the specific case, this surgery can involve the removal of individual fibroids (myomectomy) or the removal of the entire uterus (hysterectomy).
Laparoscopic, or minimally invasive, surgeries using power morcellator medical devices have been common to treat uterine fibroids. However, with the realization that there is no reliable method for predicting whether a woman with fibroids may also have an undiagnosed form of cancer known as uterine sarcoma, the FDA now discourages the use of power morcellators during myomectomy and hysterectomy procedures. The device poses a serious risk of spreading cancerous tissue throughout the patient’s abdomen.
According to the April 14th FDA statement, “If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.”
Power Morcellator and Uterine Cancer Lawsuit Inquiry
If proper warnings had been provided to patients undergoing gynecological laparoscopic surgeries with power morcellators, many would have chosen other treatment options. Manufacturers had an obligation to ensure that their device was safe for the intended purpose, and their failure to adequately warn the medical community about the risks associated with power morcellators took away many women’s ability to make educated decisions about their health and medical treatments.
At the law firm of Owen, Patterson & Owen, you will find lawyers who have broken new ground in the field of unsafe medical device litigation. Over the course of more than 30 years serving Southern California and beyond, we have obtained millions of dollars in settlements for victims of dangerous and defective medical devices and drugs. You can be confident that we can help you.
Our law firm is considered a leader in medical device litigation, a subcategory of medical malpractice. We have earned that position by using great care to research every issue before moving forward. We are currently reviewing Power Morcellator and Uterine Cancer cases.
Start with a Free Consultation. Call us at 800.676.5295 or contact us to schedule a meeting to discuss your Power Morcellator and Uterine Cancer case with an experienced attorney.